Imunon, Inc. (IMNN)

Imunon Statistics

Total Valuation

Imunon has a market cap or net worth of $9.92 million. The enterprise value is $6.04 million.

Market Cap	9.92M
Enterprise Value	6.04M

Important Dates

The last earnings date was Tuesday, May 12, 2026, before market open.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Imunon has 3.98 million shares outstanding. The number of shares has increased by 211.40% in one year.

Current Share Class	3.98M
Shares Outstanding	3.98M
Shares Change (YoY)	+211.40%
Shares Change (QoQ)	+71.90%
Owned by Insiders (%)	0.85%
Owned by Institutions (%)	4.76%
Float	3.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.73
P/TBV Ratio	2.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.27.

Current Ratio	1.59
Quick Ratio	1.15
Debt / Equity	0.27
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -768.20% and return on invested capital (ROIC) is -323.02%.

Return on Equity (ROE)	-768.20%
Return on Assets (ROA)	-124.43%
Return on Invested Capital (ROIC)	-323.02%
Return on Capital Employed (ROCE)	-384.45%
Weighted Average Cost of Capital (WACC)	14.13%
Revenue Per Employee	n/a
Profits Per Employee	-$585,681
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.16% in the last 52 weeks. The beta is 2.03, so Imunon's price volatility has been higher than the market average.

Beta (5Y)	2.03
52-Week Price Change	-69.16%
50-Day Moving Average	2.92
200-Day Moving Average	4.15
Relative Strength Index (RSI)	27.77
Average Volume (20 Days)	34,474

Short Selling Information

The latest short interest is 156,240, so 3.92% of the outstanding shares have been sold short.

Short Interest	156,240
Short Previous Month	142,264
Short % of Shares Out	3.92%
Short % of Float	4.34%
Short Ratio (days to cover)	4.67

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-14.81M
Pretax Income	-14.64M
Net Income	-14.64M
EBITDA	-14.51M
EBIT	-14.81M
Earnings Per Share (EPS)	-$4.79

Balance Sheet

The company has $4.79 million in cash and $912,000 in debt, with a net cash position of $3.88 million or $0.97 per share.

Cash & Cash Equivalents	4.79M
Total Debt	912,000
Net Cash	3.88M
Net Cash Per Share	$0.97
Equity (Book Value)	3.36M
Book Value Per Share	0.67
Working Capital	2.46M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	298,204
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Imunon does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-211.40%
Shareholder Yield	-211.40%
Earnings Yield	-147.62%
FCF Yield	n/a

Analyst Forecast

The average price target for Imunon is $10.00, which is 305.68% higher than the current price. The consensus rating is "Buy".

Price Target	$10.00
Price Target Difference	305.68%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 7, 2025. It was a forward split with a ratio of 1.15:1.

Last Split Date	Aug 7, 2025
Split Type	Forward
Split Ratio	1.15:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1